HHS names former Harvard Professor Blumenthal as National Health Care Information Technology Coordinator

HHS on Friday announced the appointment of former Harvard Medical School professor David Blumenthal as the national coordinator for health care information technology, the AP/Philadelphia Inquirer reports.

Among other responsibilities, Blumenthal, who has conducted a number of studies related to health care IT, will have a large role in the process used to determine how HHS spends the $19 billion for health care IT included in the recently enacted economic stimulus package.

Blumenthal previously served as director of the Institute for Health Policy at the Massachusetts General Hospital/Partners HealthCare System and as a senior adviser to President Obama during his campaign. In addition, he worked on the staff of Sen. Edward Kennedy (D-Mass.) in the late 1970s and served as chief health adviser to former Massachusetts Gov. Michael Dukakis (D) during his presidential campaign in 1988 (AP/Philadelphia Inquirer, 3/20).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare